Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology: Our Bureau, Mumbai ...

Zydus Medtech, a subsidiary of Zydus Lifesciences, has entered into a global licensing agreement with Brazilian medical ...

The company is rapidly expanding its interventional cardiology portfolio, and under the partnership will commercialize the ...

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation technology in India, Europe and ...

Zydus MedTech has partnered with Brazil-based Braile Biomedica to commercialize innovative TAVI technology across Europe, ...

Zydus MedTech collaborates with Braile Biomedica to commercialize TAVI technology across Europe, India, and other key markets ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve ...

Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within 72 hours ...

Whether newer pacing techniques can mitigate death, LV decline, and HF symptoms in TAVI patients remains to be seen.

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older ...